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SUMMARY
Cryptococcus neoformans (C. neoformans) is esti-
mated to cause about 220,000 new cases every year
in patients with AIDS, despite advances in antifungal
treatments. C. neoformans possesses a remarkable
ability to disseminate through an immunocom-
promised host, making treatment difficult. Here, we
examine the mechanism of survival of C. neoformans
under varying host conditions and find a role for cer-
amidesynthase inC.neoformansvirulence. Thisstudy
also provides a detailed lipidomics resource for the
fungal lipid research community in addition to discov-
ering a potential target for antifungal therapy.
INTRODUCTION
Cryptococcus neoformans (C. neoformans) is a pathogenic fun-
gus that presents a leading cause of fungal meningoencephalitis
worldwide. Recent reports reveal an annual 278,000 cases of
cryptococcal antigenemia, with cryptococcal meningitis being
the cause of 15% of AIDS-related deaths (Rajasingham et al.,
2017). Naturally occurring cases of cryptococcosis begin by
inhalation of fungal spores. Once in the lung, the outcome de-
pends largely on the immune system of the individual. In a situ-
ation of suppressed immunity, infection may lead to pneumonia
and cryptococcal meningitis. In cases of immunocompetence,
these cells are either cleared or may establish a latent infection
that will later disseminate upon future immunosuppression.
Once C. neoformans enters the lung, the cells are typically
engulfed by an alveolar macrophage in which they can survive
and replicate. Similarly, C. neoformans can survive and repli-
cate well in extracellular spaces, such as alveoli, blood, and
other tissues. Once engulfed, C. neoformans can move be-
tween the phagolysosome and extracellular space without
causing harm to the macrophage (Alvarez and Casadevall,
2006; Feldmesser et al., 2000). The intracellular and extracel-
lular environment in the host is distinguished by a prominent
difference in pH. Within the phagolysosome, the environment
pH is highly acidic, whereas the extracellular environment is
typically neutral or slightly alkaline. Adaptation to these starkly
contrasting environments is critical for C. neoformans pathoge-
nicity. There is little information regarding how C. neoformans
regulates its survival in these two host environments. Previous
studies have shown sugar-complexed sphingolipids to be
essential for the survival of C. neoformans when grown in media
mimicking host acidic or alkaline conditions. Specifically,
inositol- or mannose-containing sphingolipids are noted as
important for the survival and replication of C. neoformans in
conditions similar to the phagolysosome (Luberto et al., 2001).
Conversely, glucose-containing sphingolipids have been indi-
cated to be important for survival in conditions mimicking the
extracellular environment (Rittershaus et al., 2006). Among
sphingolipids, ceramides constitute the simplest class and the
basic backbone that precedes other more complex sphingoli-
pids (Aguilera-Romero et al., 2014). Acyl coenzyme A (CoA)-
dependent ceramide synthases catalyze the formation of cer-
amide from a fatty acyl CoA and sphingoid base. Cryptococcal
sphingolipids regulate signaling events that lead to the produc-
tion of virulence factors (Singh and Del Poeta, 2011). Studies in
C. albicans (Cheon et al., 2012), S. cerevisiae (Kageyama-Ya-
hara and Riezman, 2006), A. nidulans (Li et al., 2006), and
P. pastoris (Ternes et al., 2011) show the presence of two
distinct ceramide synthase enzymes.
Although a handful of studies reveal different characteristic
functions of ceramide synthases in each eukaryotic species,
there is still a lack of concrete evidence for the specific roles of
ceramide synthases in the context of sphingolipid biosynthesis
of fungi. In this study, we identify and characterize the ceramide
synthases ofC. neoformans, thereby elucidating several steps in
the sphingolipid biosynthetic pathway. We show that the major
ceramide synthase of this pathogen is a critical player in its path-
ogenicity, as well as the hub of numerous cellular functions. We
further highlight how a single gene has the capacity to control the
dissemination of C. neoformans, therefore suggesting a thera-
peutic target.
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RESULTS
Three Genes in C. neoformans Encode Specific Acyl-
CoA-Dependent Ceramide Synthases
On the basis of evidence of ceramide synthases in other fungi,
we performed a bioinformatic search for putative ceramide syn-
thases present in C. neoformans serotype A H99 (WT). Our anal-
ysis revealed the presence of three putative ceramide synthases
in C. neoformans. The genes CNAG_06717, CNAG_02086, and
CNAG_02087 had significant homology to other ceramide syn-
thase genes from A. nidulans, C. albicans, S. cerevisiae, and
H. sapiens (Figure 1A). They are referred to in this study as Cer1,
Cer2, and Cer3, respectively. A phylogenetic analysis showed
that Cer2 and Cer3 have high similarity to each other, as well as
to ceramide synthases of S. cerevisiae (ScLac1 and ScLag1)
and A. nidulans (AnLagA). The Cer1 amino acid sequence
is greatly diverged from Cer2 and Cer3 and has partial similarity
to ceramide synthases of C. albicans (CaLag1) and A. nidulans
Figure 1. Isolation and Characterization of
C. neoformans Ceramide Synthases
(A) Phylogenetic analysis of eukaryotic ceramide
synthases. C. neoformans has three ceramide
synthases. The entire phylogenetic tree can be
roughly divided into three major groups: human
cerS genes, the second group containing ortho-
logs of CnCer1, and the third group consisting of
S. cerevisiae Lac1 and Lag1,AnLagA,CaLac1, and
CnCer2 and CnCer3. ScLip1 is distinct from all of
these genes.
(B)Biochemical analysis ofC.neoformansceramide
synthases. Thin-layer chromatography showing
substrate specificity studies of C. neoformans cer-
amide synthases. (a) Ceramide synthase assays
using NBD-sphingosine as a substrate. Lane 1 (left)
is positive control using mammalian Cer1 micro-
somes. Negative control of each strain grown in 2%
glucose (right) (see also Figure S3). (b) Ceramide
synthase assays using NBD-phytosphingosine as a
substrate. Lane 1 (left) is positive control using
mammalian Cer1 microsomes. Negative control of
each strain grown in 2% glucose (right). Each hori-
zontal panel represents a specific strain.
(AnBarA). Reports on these genes show a
distinct specificity for synthesis of ceram-
ides used for glucosylceramide (GlcCer)
synthesis (Figure1A) (Li et al., 2006;Ritten-
our et al., 2011; Cheon et al., 2012).
An alignment of the amino acid sequences
of these genes revealed conservation of
residues that are reportedly important
for enzymatic activity (Figure S1D)
(Kageyama-Yahara and Riezman, 2006).
Ceramide Synthase Cer1 Activity
In Vitro Shows Preference for C18
Fatty Acyl CoA
To characterize the activity of each
enzyme, we generated strains over-
expressing each C. neoformans ceramide synthase in
S. cerevisiae using either a 6xHis or 3xHA tag fused protein.
These plasmids were transformed in combination into the
S. cerevisiae system to generate strains overexpressing both
Cer1-Cer2 or Cer1-Cer3. After induction, the proteins were
purified by extraction of microsomes (Ternes et al., 2011). As a
negative control, these strains were grown without induction
(2% glucose) and were used to control for any S. cerevisiae
enzyme activity (Figures S3A and S3B).
To characterize the properties of the putative ceramide
synthases, an in vitro assay for fungal ceramide synthase was
developed (see Experimental Procedures). Using a fluorescent-
labeled substrate and fatty acyl CoA, we looked for the formation
of NBD-ceramide using microsomal C. neoformans ceramide
synthase enzyme by thin-layer chromatography. We observed
that the activity of Cer1 is dependent on pH (Figure 1B) and
temperature (Figure S3C). The activity of Cer1 was optimal at
pH 7.0 and 35C.
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To systematically investigate each enzyme’s specificities,
we used combinations of fatty acyl CoAs, with either sphingo-
sine or phytosphingosine at pH 4.0 or 7.0. Cer1 showed a clear
preference for C18 fatty acyl CoA and sphingosine as a
substrate (Figure 1Ba). When phytosphingosine was used a
substrate, we observed production of C18 and C24 phytocer-
amide in slightly lower amounts (Figure 1Bb). When Cer1 and
Cer2 were co-expressed, C24 phytoceramide was the major
product. However, when Cer1 and Cer3 were co-expressed,
the enzyme activity shifted to C18 and C26 fatty acyl CoA
products (Figure 1Bb). These results suggest that the produc-
tion of ceramide isoforms is regulated by the stoichiometry of
the three ceramide synthase proteins of C. neoformans in the
presence of different substrate chain lengths. Uninduced cells
(2% glucose) showed little to no enzyme activity under these
conditions (Figure 1B).
Ceramide Synthases Are Important for the Virulence of
C. neoformans
To determine the effect of each ceramide synthase on the viru-
lence of C. neoformans, we created ceramide synthase deletion
strains in theWTC. neoformans background (Figures S1A–S1C).
Each cell line, containing a deletion cassette or a reintroduced
ceramide synthase gene, was tested on CBA/JCrHsd immuno-
competent mice. Mice were infected with a normally lethal
dose of fungal cells (73 105 cells) intranasally to establish cryp-
tococcosis and were monitored for survival. We observed that
the average survival of mice infected with WT C. neoformans
was 25 ± 6 days, while all mice infected with Dcer1 survived
(60 days of observation) (Figure 2A). The average survival of
mice infected with the reconstructed gene strain Dcer1+CER1
experienced mortality similar to the WT control, with an average
survival of 26 ± 7 days (Figure 2A). Mice infected with Dcer2
Figure 2. Ceramide Synthases Are Impor-
tant for Virulence of C. neoformans
(A) Survival studies of CBA/JCrHsd mice infected
intranasally withWT,Dcer1,Dcer1 +CER1,Dcer2,
and Dcer3. n = 10 mice per group.
(B) Histology of lung tissue forWT (at time of death)
and forDcer1 (day 60). Lung sections were stained
with H&E. (a and b) Lung of mice infected with WT.
(c and d) Lung of mice infected with Dcer1. Bars,
1,000 mm (a and c), 20 mm (b and d).
(C) Lung tissue burden analysis of WT, Dcer1, and
Dcer1+CER1. Data are expressed asmean ± SEM.
(D) Brain fungal burden analysis of WT,Dcer1, and
Dcer1+CER1. n = 3 mice at each time point.
See also Figure S2.
and Dcer3 showed a survival pattern
distinct from WT (Figure 2A), with each
deletion causing 70% mortality.
Tissue burden was assessed through-
out the course of the experiment
by removal of lungs and brain at days 0,
5, 10, and 15 post-infection. The number
ofDcer1 cells in the lung decreased start-
ing at day 5 and was reduced to 3,500
colony-forming units (CFU)/lung at day 15, showing a decrease
in lung CFU of 250-fold. At day 60, we recovered fungal cells in
the lung (500 CFU) but in only two of ten mice, suggesting
that most mice cleared the infection (Figure 2C). In contrast to
WT C. neoformans infection, Dcer1-infected mice showed no
obvious signs of discomfort throughout the course of the exper-
iment and were visually indistinguishable from uninfected mice.
The Dcer1 cells were never observed to progress to the brain
of infected mice (Figures 2D and S3A). In contrast, a significant
number of cells were found in the lungs and brain of mice in-
fected with WT and Dcer1+CER1 strains (Figures 3C and 3D).
In both these control experiments, the number of cells in the
brain increased over time, demonstrating a normal dissemina-
tion and subsequent onset of cryptococcosis. These observa-
tions were also confirmed by histopathology of the brain and
lung, in which we observed no damage to the lungs and brains
of mice infected with Dcer1 (Figure 2B). Mice infected with
WT and Dcer1+CER1 showed significant lung and brain tissue
damage (Figures 2B and S3).
To understand the inflammatory response to C. neoformans
infection in the lungs, histopathology was performed at days 1,
3, 5, and 60 (only Dcer1 mice survived to day 60). Lungs of
Dcer1-infectedmiceshowedahighdegreeof immunecell infiltrate
to the lungandalveolar spaces. As the experimentprogressed,we
observedprogressive clearing of the immunecell infiltrate (Figures
2B and S3B). Cells ofDcer1 could be observed in several areas of
the lung until day 5. These cells appeared to have difficulty
completing replication and had a pseudohyphal morphology.
Lungs infectedwithWTshowedapersistentlyhigh level of immune
cell infiltrate throughout the time course, enlarged C. neoformans
capsules, and fungal pneumonia, which was not observed for
Dcer1 (Figure S2B). The total burden of WT C. neoformans cells
increased throughout the time course (Figure 2).
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Identification of Lipid Changes on Ceramide Synthase
Deletion
The sphingolipid pathway in C. neoformans can be separated
into two major branches: substrates that lead to the generation
of glucose-containing sphingolipids such as GlcCer and those
that lead to inositol-containing sphingolipids such as inositol
phosphorylceramide (IPC). To assess the specific roles of each
gene in lipid metabolism, we analyzed each knockout strain
with lipidomic-focused mass spectrometry. The analysis was
performed on cells grown in in vitro conditions (5% CO2, 37
C,
DMEM) mimicking host-like growth conditions.
Because fungal cells produce a diverse array of ceramide spe-
cies, we developed mass spectrometry detection protocols for
an array of the most abundant ceramide lipids. When exposed
to an acidic environment, WT C. neoformans showed accumula-
tion of dihydrosphingosine as well as higher total biomass of
GlcCer species (Figure 3). We also observed higher abundance
of phytosphingosine and certain long-chain a-OH phytocera-
mides (C24, C26). This increase was propagated downstream
in the pathway by increased levels of 42:0:4, 42:0:5, and
44:0:4 chain length IPCs (Figures 3 and S4). In contrast, at
alkaline pH, sphingosine-1-phosphate, dihydrosphingosine-1-
phosphate, and phytosphingosine-1-phosphate were twice as
abundant as those in acidic pH (Figure S4). Therefore, the data
show not only that C. neoformans changes the metabolism of
several lipid species when it is exposed to different host condi-
tions but, more important, that this change depends on specific
ceramide isoforms to generate sufficient amounts of the result-
ing complex sphingolipids. The lipid profile of Dcer1 was signif-
icantly perturbed fromWT compared with themilder phenotypes
of Dcer2 and Dcer3. We observed that Cer1 was the major cer-
amide synthase responsible for using C18 fatty acyl CoA to
generate C18 ceramides (Figures 1B and 3). As C18 ceramides
are required to synthesize aOH-C19:2/C18 GlcCer, the most
abundant GlcCer in either condition, the strain Dcer1 is lacking
the vast majority of its normal glucose-containing complex
Figure 3. Sphingolipid Biosynthetic Pathway and Ceramide Species Abundance of C. neoformans Ceramide Synthase Mutants and WT in
Distinct Host Conditions In Vitro Using MS Analysis
(A) Changes in specific lipid classes at pH 4.0.
(B) Changes in specific lipid classes at pH 7.4.
(C and D) Abundance of complex sphingolipid species in WT and ceramide synthase mutants at pH 4.0 (C) and 7.4 (D). All the lipids are normalized to dry lipid
weight.
Data are expressed as mean ± SEM. aOH-PCER, a-hydroxy-phytoceramide; CER, ceramide; DHC, dihydroceramide; DHS, dihydrosphingosine; GlcCer, glu-
cosylceramide; IPC, inositolphosphoryl ceramide; PCER, phytoceramide; PHS, phytosphingosine. See also Figure S4 and Tables S2 and S3.
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sphingolipids (Figure 3C). C24 and C26 lipids were not signifi-
cantly depleted in the Dcer1 strain but also represented a tiny
fraction of total GlcCer abundance in the WT strain (Figure 3C).
This observation agrees with the in vitro findings of chain-length
specificity for Cer1 (Figure 1B). In the Dcer1 strain, depletion of
IPCs generated from non-hydroxylated and a-hydroxylated
C18 phytoceramides contrasts with the accumulation of
long-chain IPCs. Notably, Dcer1 and Dcer3 showed a signif-
icant depletion of C26 phytoceramides in acidic conditions
(Figure 3A).
These data indicate that upon loss of Cer1, Cer2 and Cer3
can partially compensate for production of certain sphingolipid
isoforms but are insufficient for production of the major C18 cer-
amide isoforms. Broadly speaking, of the lipid isoforms showing
significant change, these changes were most pronounced under
acidic conditions (Figures 3 and S5). The levels of the major IPC,
IPC 42:0:4, remained relatively unchanged in the deletion strains.
Dcer2 showed little to no depletion of lipids but a marked in-
crease in dihydrosphingosine, C18 dihydroceramide, and total
short-chain GlcCers. Additionally, Dcer2 showed a clear abun-
dance of most C18 lipids in the IPC pathway: phytosphingosine,
phytoceramides, aOH phytoceramides, and C36 IPCs all were
significantly more abundant compared with WT. Meanwhile,
Dcer3 showed a decrease in lipids along the GlcCer branch of
the pathway as well as a decrease in C24 and C26 lipids in the
IPC pathway under alkaline conditions. Together, these data
suggest that Cer1 is critical for the biosynthesis of C18 ceram-
ides, whereDcer2 andDcer3 showmore subtle lipid phenotypes
and appear to fine-tune the abundance of less common lipids
(Figure S4; Data S1).
Effect of Ceramide Synthase on the In Vitro Growth of
C. neoformans
To evaluate the effect of gene deletion in in vitro cell culture
growth, we performed growth assays of C. neoformans WT,
Dcer1, and Dcer1+CER1 strains. Growth was analyzed in condi-
tions mimicking host intracellular and extracellular conditions,
using DMEM at neutral/alkaline or acidic conditions at 37C
and 5% CO2. As shown in Figures 4A and 4B, Dcer1 cells
showed a distinct lack of growth at both conditions mimicking
host environments. Dcer1 viability began to decrease at 24 hr
in acidic as well as alkaline conditions. Loss of viability was not
observed at 30C and atmospheric level of CO2 (Figure 4C).
These results indicate the deletion of Dcer1 is important for the
survival and proliferation of C. neoformans in host intracellular
and extracellular conditions.
To determine the effect of cell wall stress on the deletion
strains, a spot assay was performed by exposing WT, Dcer1,
and Dcer1+CER1 to 0.03% SDS. We observed that Dcer1 was
more sensitive to cell wall stress compared with WT and
Dcer1+CER1 (Figure 4D). We tested the resilience of these
strains to oxidative stress by exposing dilutions of these cells
to hydrogen peroxide at pH 4 and 7.4 (Figure 4D). Dcer1was hy-
persensitive to oxidative stress at both pH values. The hypersen-
sitivity of Dcer1 to low pH and other stresses are significant
considering that the spot assay was done using rich medium
(YPD) because it could not be performed in minimum medium
for the growing defect phenotype of the mutant.
Phenotype Analysis of Ceramide Synthase Mutant
Strains
To assess the physiological effects of the deletion of ceramide
synthasegenes,weanalyzed thephenotypes of thesecells under
several conditions with a focus on alteration of virulence factors.
The deletion of Cer1, but not Cer2 or Cer3, generated defects in
cell morphology. Capsule visualization by India ink staining re-
vealed that cells of Dcer1 had cell division defects leading to
the development of elongated cells with a smaller capsule (Fig-
ure S5B). WhenDcer1was grown in rich medium (YPD), the cells
showed normal morphology, with a few cells showing multiple
enlarged buds that remained attached. However, upon transfer
to host-like growth conditions (5% CO2, 37
C, DMEM), Dcer1
cells showed gross morphological defects and inability to com-
plete cytokinesis. A lifespan study of these cells showed that
the average replicative lifespan (RLS) of Dcer1was only 6.5 gen-
erations, whereas those of WT and Dcer1+CER1were 27 and 30
generations respectively (Figure S5A). For Dcer1, after 6.5 ± 2
generations, the cells formed elongated pseudohyphal-like
structures in which new buds were impossible to separate from
the mother cell. Despite the inability to separate, the cells
continued to elongate for several hours.
We performed transmission electron microscopy to further
observe these changes in cellular structure. Dcer1 cells showed
detachment of the cell wall from the plasma membrane in many
cells. The elongated ‘‘hyphal-like’’ structures observed in histo-
logical and India ink staining were found to be daughter cells
that were unable to complete cytokinesis. Interestingly, we
also observed that the cell wall structure of Dcer1 looked very
different from that of WT. Although the WT cells showed
well-defined, distinct layers resulting in a compact cell wall, the
cell wall of Dcer1 appeared less compact, with no clear separa-
tion between cell wall layers (Figure 4E). The fibrillar structures
forming the polysaccharide capsule were smaller and less
distinct than that of WT (Figure 4E). We hypothesize that the
layers of the cell wall of Dcer1 are inhibitory to cytokinesis and
cell separation under two conditions: when the cells are exposed
to host-like conditions and when cells are grown in the absence
of rich, ceramide lipid-containing media. To confirm the role of
ceramides in the formation of such a drastic cellular defect, the
cells of Dcer1 were supplemented with a cocktail of natural
ceramides (Matreya). Upon supplementation, we observed that
many of the previously observed cellular defects were recovered
(Figure 4E). This cocktail predominantly contains a mixture of
C18 and C24 hydroxylated and non-hydroxylated ceramides.
Together these observations suggest that ceramides synthe-
sized by Cer1 are critical for proper cytokinesis in stressful
host conditions, in which increased cell wall thickness intro-
duces a hindrance for proper daughter cell budding.
C18 Ceramides Generated by Cer1 Are Important for
Acidic Tolerance of C. neoformans
Wechecked theefficiencyof theplasmamembraneprotonpump,
Pma1, upon deletion of a ceramide synthase in C. neoformans.
Pma1 is a crucialmediator ofC. neoformans virulence, as the pro-
ton pump regulates C. neoformans cytosolic pH. This is a partic-
ularly important function for C. neoformans growth inside acidic
macrophage lysosomes. A colorimetric pH indicating dye was
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used to measure glucose-dependent proton efflux over a time
course (Soteropoulos et al., 2000). Our results showed that
Dcer1 cells acidify medium at a much slower rate than WT and
Dcer1+CER1 strains (Figure 4F). We observed an increase in
Pma1 efficiency in Dcer1 cells upon supplementation with C18
ceramide (Figure 4F). To further confirm to the role of ceramides
in the observed phenotypes, we tested Pma1 activity of Dgcs1
strain, as well as the Dgcs1 strain treated with an IPC1 inhibitory
drug, aureobasidin A (AbA). We observed that Dgcs1 had high
Pma1 activity, which was reduced upon treatment with AbA (Fig-
ure 5A). Interestingly, supplementation with C18 ceramides, but
not phytoceramides, increased Pma1 activity of AbA-treated
Dgcs1 cells (Figure 5A). To ensure that the Pma1 activity data
were not attributable to higher or lower rates of cell death, we
measured cell viability at the end of each experiment and found
no difference between strains (data not shown). To further clarify
the role of intermediate ceramides,weuseda genetically downre-
gulated IPC1 strain (GAL7::IPC1) that has been reported to show
reduced growth in acidic conditions. The growth defect of this
strain was compensated by supplementation C18 ceramide and
to a smaller extent by C6 phytoceramide (Figure 5B). These data
indicate that the intermediate ceramide isoforms, not the terminal
Figure 4. Phenotypic Analysis of Ceramide Synthase Mutants
(A) In vitro growth of WT, Dcer1, and Dcer1+CER1 at 37C, 5% CO2, pH 4.0 (intracellular).
(B) In vitro growth of WT, Dcer1, and Dcer1+CER1 at 37C, 5% CO2, pH 7.4 (extracellular).
(C) In vitro growth of WT and Dcer1 in YPD, 30C, 0.04% CO2.
(D) Serial dilutions of WT, Dcer1, Dcer1 +CER1, Dcer2, and Dcer3 on solid YPD media supplemented with SDS or H2O2.
(E) Transmission electron microscopy of WT, Dcer1, and Dcer1 supplemented with ceramide mixture (Matreya). Bar, 500 nm.
(F) Pma1 proton pump activity of WT, Dcer1, Dcer1+CER1, and Dcer1 + C18 ceramide (Avanti Polar Lipids) measured by glucose-dependent medium acidifi-
cation. Data are expressed as mean ± SEM.
For (A)–(C), data are expressed as mean ± SEM.
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IPC and GlcCer isoforms, play a major role in regulation of Pma1
and normal cell growth.
DISCUSSION
An understanding of the mechanisms driving C. neoformans
pathogenicity is an increasingly important area of research
because of the growing number of cases of cryptococcosis
worldwide. Deeper insight into how this pathogen efficiently
maintains itself within immunocompromised hosts will bring
us to closer to finding a way to control its growth and dissem-
ination. Dynamic adjustment of the sphingolipid profile in
C. neoformans cells has been reported to play a significant
role in C. neoformans’s ability to grow in either highly acidified
phagocytic environment or slightly alkaline blood, alveolar, and
brain tissue environments. Previous studies attempting to eluci-
date this pathway have uncovered important pieces of this puz-
zle (Del Poeta et al., 2015; Rittershaus et al., 2006; Luberto
et al., 2001). In the present study, we provide a more compre-
hensive view of the involved genes and show their importance
in the lipid profile switch between these two contrasting
environments.
Figure 5. Effect of Ceramide on Pma1 Activ-
ity and on Cell Growth
(A) Pma1 proton pump activity of WT, Dcer1,
Dgcs1, Dgcs1+AbA, Dgcs1+AbA+C6 phytocer-
amide, and Dgcs1+AbA+C18 ceramide measured
by glucose-dependent medium acidification. Data
are expressed as mean ± SEM.
(B) In vitro growth of WT, GAL7::IPC1, GAL7::
IPC1+C6 phytoceramide, GAL7::IPC1+ C18 cer-
amide, and Dcer1 at 37C, 5% CO2, pH 4.0. Data
are expressed as mean ± SEM.
Here, we show that ceramide synthase
Cer1 is a major factor in the pathogenicity
ofC. neoformans. We observed that dele-
tion of each ceramide synthase showed a
survival curve that was significantly
divergent from WT infection, with Dcer1
being completely avirulent with 80% of
mice totally clearing the infection within
60 days. Lack of in vitro growth in host
intracellular and extracellular conditions
suggests that Dcer1 lacks the ability to
efficiently thrive in the host upon infec-
tion. In stark contrast to previous studies
on Dgcs1 and GAL7::IPC1, cells of Dcer1
quickly begin to die when grown in mini-
mal medium conditions regardless of
either pH. An inhibitor of Cer1 could
potentially be a very good drug for the
treatment of cryptococcosis and other
fungal diseases.
There are studies that suggest a
role of phytoceramides in the activity
of plasma membrane proton pumping
H+-ATPase, Pma1 (Farnoud et al., 2014; Keniya et al., 2013;
Soteropoulos et al., 2000). Our results show that Dcer1 has
a marked reduction in the activity of Pma1, thereby suggesting
a role, possibly through an indirect mechanism, of C18 ceram-
ides in the ability of C. neoformans to maintain its survival
within the highly acidic phagolysosome. Increased Pma1 ac-
tivity in the Dgcs1 mutant suggests two possible models of
ceramide species mediated regulation of Pma1: it is possible
that the lack of GlcCer species in Dgcs1 relieves an inhibitory
pressure on Pma1 activity, causing the observed increase.
Alternatively, a buildup of intermediate ceramide compounds
or IPCs in response to a lack of Gcs1 (Table S2) could have
a positive effect on Pma1 activity, which could also result in
the observed increase. Pma1 activity in the presence of AbA
and Dgcs1 indicates intermediate ceramide compounds play
a major role in the enzyme’s activity.
Dcer1 cells have critical defects in cytokinesis in the presence
of host-like environmental stresses. The cell wall is improperly
anchored to the plasma membrane in many cells; consequently
the membrane and cell wall structure may be inhibiting daughter
cell separation. It remains unclear if the altered morphology of
the cell wall or the lack of cell wall adherence to the plasma
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membrane is the major contributor to this phenotype. The pres-
ence of irregular amounts of long-chain ceramides and complex
sphingolipids could be affecting the rigidity of the cell wall and/or
plasma membrane.
We observed that each knockout strain had distinct alterations
of ceramides and downstream lipids, as shown by lipidomic
analysis, indicating that the genes are not functionally redun-
dant, and each likely plays a specific role in maintaining the op-
timum lipid profile for C. neoformans membranes. Despite
numerous attempts to create a double-mutant Dcer2Dcer3, we
have been unsuccessful. We suspect, but are unable to confirm
because of tight genetic linkage, that the presence of either Cer2
or Cer3 is essential to cell survival. Furthermore, the inability of
Dcer1 cells to survive in acidic conditions, despite abundant
amounts of IPC-42:0:4, strongly suggests an important role of
C18 ceramides for this phenotype.
In summary, this study is a novel insight into the critical impor-
tance of ceramides and ceramide synthases in cryptococcal
pathogenicity. Cer1 predominately uses C18 fatty acid chain
substrates in order to synthesize specific ceramides and com-
plex sphingolipids that are of crucial importance toward
C. neoformans pathogenicity. Our results can be extrapolated
to several other pathogenic fungi and therefore provide new
hope for immunocompromised individuals susceptible to fungal
infections.
EXPERIMENTAL PROCEDURES
Strains, Plasmids, and Media
The strains used in this study are C. neoformans var. grubii strain H99 as
wild-type (WT) and S. cerevisiae BY4741. The bacterial strain used was
Escherichia coli DH5-a Max Efficiency (Invitrogen, Carlsbad, CA, USA) as
competent cells. The three putative ceramide synthase genes in this study
have the following identifiers: CNAG_06717 (GenBank: XM_012192296),
CNAG_02086 (GenBank: XM_012194542), and CNAG_02087 (GenBank:
XM_012194543). pYES2/CT was used for overexpression of CNAG_06717
in S. cerevisiae BY4741 and pRS425 for CNAG_02086 and CNAG_02087.
C C. neoformans strains were routinely grown in YPD broth at 30C and
0.04% CO2 shaking overnight. DMEM buffered with 25 mM HEPES (pH 4.0
or 7.4) was used to grow C. neoformans at 37C in the presence of 5% CO2.
S. cerevisiae transformed with pYES2/CT was grown in YNB (ura), and
S. cerevisiae transformed with pRS425 was grown in synthetic leucine (leu)
dropout media. Strains containing both vectors were grown in synthetic
leuura dropout media. Bacterial strains were grown at 37C in Luria-Bertani
media containing 75 mg/L of ampicillin (Sigma-Aldrich). All primers are speci-
fied in Table S1.
Phylogenetic Analysis of Putative Ceramide Synthase Genes
Exact maximum likelihood phlyogenetic tree construction was performed us-
ing TreePuzzle (Schmidt et al., 2002; Schmidt and Von Haeseler, 2007) with
1,000 quartet puzzling steps. Dendroscope was used to visualize the resulting
phylogenetic tree (Huson et al., 2007; Huson and Scornavacca, 2012).
Fluorescent Cryptococcal Ceramide Synthase Assay
An assay for ceramide synthase activity was adapted (Kim et al., 2012; Tidhar
et al., 2015) with minor changes. Enzymes were extracted as microsomes
(see Supplemental Experimental Procedures). Reactions contain 10 mM
NBD-sphingosine or NBD-phytosphingosine (Avanti Polar Lipids) and 50 mM
fatty acyl CoA (C18, C24, C26) (Avanti Polar Lipids, Alabaster, AL, USA).
One hundred fifty micrograms of microsomal protein was added per reaction.
Reactions were incubated at 35C for 90 min, followed by enzyme inactivation
with 2:1 chloroform/methanol. The lipids were extracted and dried in a
SpeedVac (SPD 2010; Thermo Fisher Scientific) and resuspended in 100%
methanol. The reaction was analyzed using thin-layer chromatography, using
chloroform/methanol/water (8:1:0.1, v/v/v) as the solvent mixture.
Virulence Studies andHistologyAnalysis in aMurineMouseModel of
Cryptococcosis
Three- to 4-week-old female CBA/JCrHsd mice (Harlan Laboratories) were
used for all experiments. Mice were infected with WT, Dcer1, Dcer2, Dcer3,
andDcer1+CER1 at a concentration of 3.53 107 cells/mL. For survival studies,
ten CBA/JCrHsd mice per strain were infected intranasally with 7 3 105
cells/20 mL. For tissue burden analysis, ninemice per strain were used. Organs
were excised and homogenized in 10 mL PBS using Stomacher 80 (Seward)
for 2 min at high speed. For histopathology analysis, three mice per experi-
mental group were used. Mice organs were fixed in 3.7% formaldehyde
in paraffin and stained with H&E and mucicarmine. All animal procedures
were approved by the Stony Brook University Institutional Animal Care and
Use Committee and followed the guidelines of American Veterinary Medical
Association.
Extraction and Mass Spectrometry Analysis of Yeast Sphingolipids
Lipid extraction was performed according to the methods of Bligh and Dyer
(1959). After measuring the dry weights, the samples were subject to base hy-
drolysis (Clarke and Dawson, 1981). The extracts were dried in a SpeedVac
(SPD 2010, ThermoFisher Scientific, Waltham, MA, USA). All internal stan-
dards were added prior to lipid extraction. Mass spectrometry (MS) analysis
detailed in Supplemental Experimental Procedures.
In Vitro Growth Studies
Cells of C. neoformans WT, Dcer1, and Dcer1+CER1 were grown in 10 mL
DMEM (buffered with HEPES [pH 4.0 or 7.4]) to a final density of 104 cells/mL
and incubated in shaker incubator at 37C with 5% CO2 or YPD (30C, 0.04%
CO2) where mentioned. GAL7::IPC1 was grown as previously described
(Luberto et al., 2001). Aliquots were taken at the time points indicated. For
cell wall stability, cells were spotted in serial dilutions on YPD plates with
0.05% SDS. For oxidative stress, cells were spotted on YPD containing
2 mM H2O2. C6 phytoceramide (50 mM) (Matreya) and C18 ceramide (Avanti
Polar Lipids) were supplemented where mentioned.
Transmission Electron Microscopy
C. neoformans strains were grown for 24 hr in DMEM (pH 4.0 or 7.4) at
37C + 5% CO2. Cells were later washed and fixed in 3% EM-grade glutaral-
dehyde solution for 2 hr. Cells were supplemented with 50 mM ceramide mix
where indicated (Matreya). (Additional sample preparation details are provided
in Supplemental Experimental Procedures.) Visualization of samples was per-
formed using a FEI TeCnai12 BioTwinG2 transmission electron microscope.
Digital images were acquired with an AMT XR-60 charge-coupled device
(CCD) digital camera system.
Glucose-Dependent Medium Acidification to Measure Plasma
Membrane H+-ATPase
Glucose-dependent medium acidification was monitored by a modification of
a procedure described previously (Perlin et al., 1988; Soteropoulos et al.,
2000). Briefly, cells of WT, Dcer1, Dcer1+CER1, and Dgcs1 were grown to
mid-log phase in YPD. The following day, cells were transferred to DMEM at
pH 4.0 for 24 hr. AbA (0.05 mg/mL) and 50 mM ceramide supplements were
added where mentioned. Cells were then harvested, washed, and resus-
pended in 100 mM KCl (pH 5.0), shaking at 30C for 1 hr. These samples
were then stored at 4C overnight prior to use. For the assay, cells were
concentrated to a final A590 of approximately 2.0. Twenty microliters of cells
along with 155 mL of bromophenol blue (50 mg/mL) in 100 mM KCl (pH 5.0)
and 20 mL 20% (w/v) glucose was added to initiate the reaction. Medium acid-
ification wasmonitored at 590 nmover a period of 5 hr (data point every 3mins)
in a microplate reader (SpectraMax M5)
Statistics
Data are expressed as mean ± SEM. Calculations were made and data
graphed using GraphPad Prism software version 6.0.
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SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
five figures, three tables, and one data file and can be found with this article
online at https://doi.org/10.1016/j.celrep.2018.01.035.
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